Small cell carcinoma of the esophagus; Clinicopathological and immunohistochemical analysis of six cases

Diseases of the Esophagus

Volumn 16, Issue 3, 2003, Pages 252-258

  Noguchi, Tsuyoshi ^a   Takeno, S ^a   Kato, T ^a   Wada, S ^a   Noguchi, T ^a   Uchida, Y ^a   Kashima, K ^a   Yokoyama, S ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Bombesin; CD56; CD57; Immunohistochemistry; Small cell carcinoma of the esophagus

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; BOMBESIN; BOMBESIN POLYCLONAL ANTIBODY; CD56 ANTIGEN; CD56 MONOCLONAL ANTIBODY; CD57 ANTIGEN; CD57 MONOCLONAL ANTIBODY; CHROMOGRANIN A; CHROMOGRANIN A POLYCLONAL ANTIBODY; CISPLATIN; CYCLOPHOSPHAMIDE; EPIPODOPHYLLOTOXIN DERIVATIVE; ETOPOSIDE; IRINOTECAN; NEURON SPECIFIC ENOLASE; NEURON SPECIFIC ENOLASE MONOCLONAL ANTIBODY; PREDNISOLONE; SYNAPTOPHYSIN; SYNAPTOPHYSIN POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE MARKER; ESOPHAGUS CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REACTION ANALYSIS; SMALL CELL CARCINOMA;

AGED; CARCINOMA, SMALL CELL; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED;

EID: 0242606368     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2003.00341.x     Document Type: Article

References (30)

1. Tanabe G, Kajisa T, Shimazu H, Yoshida A. Effective chemotherapy for small cell carcinoma of the esophagus. Cancer 1987; 60: 2613-26.
2. Mori M, Matsukuma A, Adachi Y, et al. Small cell carcinoma of the esophagus. Cancer 1989; 63: 564-83.
3. McFadden D W, Rudnicki M, Talamini M A. Primary small cell carcinoma of the esophagus. Ann Thorac Surg 1989; 47: 477-80.
4. Law S Y, Fok M, Lam K Y, Loke S L, Ma T, Wong J. Small cell carcinoma of the esophagus. Cancer 1994; 73: 2894-9.
5. Craig S R, Carey F A, Walker W S, Cameron E W. Primary small-cell cancer of the esophagus. J Thorac Cardiovasc Surg 1995; 109: 284-8.
6. Huncharek M, Muscat J. Small cell carcinoma of the esophagus. The Massachusetts General Hospital experience, 1978 to 1993. Chest 1995; 107: 179-81.
7. Medgyesy C D, Wolff R A, Putnam J B Jr, Ajani J A. Small cell carcinoma of the esophagus: The University of Texas M. D. Anderson Cancer Center experience and literature review. Cancer 2000; 88: 262-7.
8. Osugi H, Takemura M, Morimura K, et al. Clinicopathologic and immunohistochemical features of surgically resected small cell carcinoma of the esophagus. Oncol Rep 2002; 9: 1245-9.
9. Bostwick D G, Roth K A, Evans C J, Barchas J D, Bensch K G. Gastrin-releasing peptide, a mammalian analog of bombesin, is present in human neuroendocrine lung tumors. Am J Pathol 1984; 117: 195-200.
10. Bostwick D G, Bensch K G. Gastrin releasing peptide in human neuroendocrine tumours. J Pathol 1985; 147: 237-44.
11. Springall D R, Ibrahim N B, Rode J, Sharpe M S, Bloom S R, Polak J M. Endocrine differentiation of extra-pulmonary small cell carcinoma demonstrated by immunohistochemistry using antibodies to PGP 9.5, neuron-specific enolase and the C-flanking peptide of human pro-bombesin. J Pathol 1986; 150: 151-62.
12. Kaufmann O, Georgi T, Dietel M. Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. Hum Pathol 1997; 28: 1373-8.
13. Morice W G, Ferreiro J A. Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry. Hum Pathol 1998; 29: 609-12.
14. Sobin L H, Wittekind C H. Classification of Malignant Tumours, 5th edn. Wiley-Liss, 1997: 54-8.
15. Moody T W, Pert C B, Gazdar A F, Carney D N, Minna J D. High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science 1981; 214: 1246-8.
16. Wood S M, Wood J R, Ghatei M A, Lee Y C, O'Shaughnessy D, Bloom S R. Bombesin, somatostatin and neurotensin-like immunoreactivity in bronchial carcinoma. J Clin Endocrinol Metab 1981; 53: 1310-12.
17. Pert C B, Schumacher U K. Plasma bombesin concentrations in patients with extensive small cell carcinoma of the lung. Lancet 1982; 1: 509.
18. Erisman M D, Linnoila R I, Hernandez O, DiAugustine R P, Lazarus L H. Human lung small-cell carcinoma contains bombesin. Proc Natl Acad Sci USA 1982; 79: 2379-83.
19. Koppan M, Halmos G, Arencibia J M, Lamharzi N, Schally A V. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma. Cancer 1998; 83: 1335-43.
20. Yang H K, Scott F M, Trepel J B, Battey J F, Johnson B E, Kelley M J. Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an anti-bombesin antibody in small-cell lung cancer cell lines. Lung Cancer 1998; 21: 165-75.
21. Kiaris H, Schally A V, Nagy A, Sun B, Armatis P, Szepeshazi K. Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice. Br J Cancer 1999; 81: 966-71.
22. Chaudhry A, Carrasquillo J A, Avis I L, et al. Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clin Cancer Res 1999; 5: 3385-93.
23. Cuttitta F, Carney D N, Mulshine J, et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985; 316: 823-6.
24. Bunn P A Jr, Linnoila I, Minna J D, Carney D, Gazdar A F. Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express the Leu-7 antigenic determinant present on natural killer cells. Blood 1985; 65: 764-8.
25. Ordonez N G. Desmoplastic small round cell tumor: II. An ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am J Surg Pathol 1998; 22: 1314-27.
26. Kibbelaar R E, Moolenaar C E, Michalides R J, Bitter-Suermann D, Addis B J, Mooi W J. Expression of the embryonal neural cell adhesion molecule N-CAM in lung carcinoma. Diagnostic usefulness of monoclonal antibody 735 for the distinction between small cell lung cancer and non-small cell lung cancer. J Pathol 1989; 159: 23-8.
27. Aletsee-Ufrecht M C, Langley K, Rotsch M, Havemann K, Gratzl M. NCAM: A surface marker for human small cell lung cancer cells. FEBS Lett 1990; 267: 295-300.
28. Rygaard K, Moller C, Bock E, Spang-Thomsen M. Expression of cadherin and NCAM in human small cell lung cancer cell lines and xenografts. Br J Cancer 1992; 65: 573-7.
29. Brezicka F T, Olling S, Bergman B, et al. Immunohistochemical detection of two small cell lung carcinoma-associated antigens defined by MAbs F12 and 123C3 in bronchoscopy biopsy tissues. APMIS 1991; 99: 797-802.
30. Roy D C, Ouellet S, Le Houillier C, Ariniello P D, Perreault C, Lambert J M. Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin. J Natl Cancer Inst 1996; 88: 1136-45.